A Double-Blind, Placebo-Controlled Study of Brexpiprazole in the Treatment of Borderline Personality Disorder
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2018
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- 03 Dec 2018 Status changed from not yet recruiting to recruiting.
- 16 Nov 2018 Planned initiation date changed from 1 Oct 2018 to 15 Nov 2018.
- 18 Oct 2018 Planned initiation date changed from 1 Jul 2018 to 1 Oct 2018.